We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 516

WHO Urges End to Routine Antibiotic Use in Food-Producing Animals
  • Keller and Heckman LLP
  • USA, Global
  • November 13 2017

For years, FDA, USDA, and various industry stakeholders have sought to tackle public health concerns associated with the use of medically important

Healthcare goes digital but regulation hard to disrupt
  • Baker McKenzie
  • USA, Global
  • October 28 2017

Healthcare technology is at a pivotal moment in its development. The healthcare industry is primed to take advantage of the innovative tools that

Clinical trials in China
  • Ropes & Gray LLP
  • China, Global
  • October 12 2017

A structured guide to clinical trials in China

Clinical trials in the USA
  • Perkins Coie LLP
  • USA, Global
  • October 11 2017

A structured guide to clinical trials in the USA

Life sciences: product regulation and liability in the USA
  • Perkins Coie LLP
  • USA, Global
  • October 11 2017

A structured guide to product regulation and liability in the USA

International Trade Compliance Update - October 2017
  • Baker McKenzie
  • USA, Global
  • October 10 2017

On September 5, 2017, United States Trade Representative Robert Lighthizer, Canadian Foreign Affairs Minister Chrystia Freeland and Mexican Secretary

Global Privacy & Cybersecurity Update Vol. 15
  • Jones Day
  • USA, European Union, Global
  • September 13 2017

On June 19, the Federal Trade Commission ("FTC") submitted comments to a working group organized by the Department of Commerce's National

Guidebook: Cybersecurity in the Pharma, Biotech, and Medical Devices Industries
  • Foley & Lardner LLP
  • USA, Global
  • April 3 2017

As a life sciences or medical device company, it is mission critical to protect lab books, drug and clinical test data, product Formula

Food & Beverage Litigation Update: Issue 615
  • Shook Hardy & Bacon LLP
  • USA, United Kingdom, European Union, Global
  • August 26 2016

The U.S. Food and Drug Administration (FDA) has extended the public comment periods for draft guidance "that provides practical, voluntary sodium

IGPA 2015 focuses on biosimilars, quality, and harmonization in Toronto-part two of two
  • McGuireWoods LLP
  • Global
  • September 22 2015

This is the second part of coverage of the 18th Annual International Generic Pharmaceutical Alliance (IGPA) Meeting held in Toronto, Canada on